Immune to Cancer: The CRI Blog
-
CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines
Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research
It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments… -
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
CRI’s Wear White Luncheon Raises Over $30,000
By Rebecca Jensen The Cancer Research Institute held its fourth annual Wear White Luncheon, hosted by Mary… -
Why Do We Get Cancer? How Our Lifestyles Impact Our Risk
There are many factors that dictate whether someone will develop cancer, and they fall roughly into two… -
Rising Female Talents in Cancer Immunotherapy Research
In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,… -
ASCO 2023 Preview — Partnering with Patients: The Cornerstone of Cancer Care and Research
This weekend, the highly anticipated 2023 annual meeting of the American Society of Clinical Oncologists (ASCO) takes…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.